Crescent Biopharma, Inc.
CBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37,879 | -$36,899 | -$46,689 | -$63,427 |
| Dep. & Amort. | $35 | $153 | $207 | $265 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $0 | $3,560 | $3,858 | $6,087 |
| Change in WC | $1,159 | -$2,559 | -$4,662 | -$1,165 |
| Other Non-Cash | $5,587 | $865 | $829 | $749 |
| Operating Cash Flow | -$31,098 | -$34,880 | -$46,457 | -$57,490 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$10 | -$21 | -$84 | -$15 |
| Net Acquisitions | $30 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $20 | -$21 | -$84 | -$15 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $5 | $28,707 | $4,157 | $10,699 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $116 | $0 | $25 |
| Financing Cash Flow | $5 | $28,824 | $4,157 | $10,724 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$31,073 | -$6,078 | -$42,384 | -$46,780 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $41,793 | $47,871 | $90,255 | $137,035 |
| End Cash | $10,720 | $41,793 | $47,871 | $90,255 |
| Free Cash Flow | -$31,108 | -$34,901 | -$46,542 | -$57,504 |